小分子在治疗牛皮和牛皮关节炎中的作用
Venkata Chalam Konakanchi1, Bikash R Kar2, Dharshini Sathishkumar3
1From the Department of DVL, RIMS, Srikakulam, Andhra Pradesh, India.
Indian journal of dermatology
|August 9, 2024
概括
新的小分子为牛皮提供了有前途的局部和口服治疗方法,提供有效的疾病控制,副作用比生物药物少. 这些进展旨在在管理这种慢性皮肤疾病时实现长期缓解.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮是一种常见的慢性,免疫介导的炎症性皮肤疾病.
- 管理是复杂的,受疾病程度,并发症,生活质量和患者偏好的影响.
- 目前的治疗方法在平衡疗效,副作用和长期缓解方面面临挑战.
研究的目的:
- 探索牛皮治疗方式的进步.
- 突出新型小分子抑制剂作为治疗选择的发展.
- 为了比较小分子对生物药物的优势,在牛皮管理中.
主要方法:
- 对了解牛皮病原体的最近发展情况的回顾.
- 分析新兴的局部和口服小分子疗法.
- 基于患者和医生的偏好,对小分子与生物制剂进行比较评估.
主要成果:
- 了解牛皮病原体已经推动了治疗的进化,包括生物药物和小分子.
- 由于避免注射和相关的副作用,小分子比生物药物更受欢迎.
- 与生物相比,小分子也更经济.
结论:
- 新的小分子,无论是局部还是口服,都代表了牛皮治疗武器库的有希望的补充.
- 这些药物为有效的疾病控制提供了潜力,改善了安全性和成本效益.
- 未来的牛皮病管理可能会从这些不断发展的小分子疗法中显著受益.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
T Cell Types and Functions
966
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
966
Drugs Used in Lower Respiratory Disorders: Overview
383
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
383
Antiasthma Drugs: Leukotriene Modifiers
267
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
267
Drugs for Treatment of Ulcerative Colitis in IBD
133
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
133
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149


